October 23, 2020
Article
The findings of this multicenter cohort may have implications for diagnosis, prognosis, and disease monitoring, as well as for clinical trials targeting disease-specific proteins in DLB.
September 25, 2020
The treatment could also be used for Alzheimer disease and mid-stage Huntington disease for patients who suffer from greater cognitive deficits.
September 19, 2020
Sumifilam could be the first Alzheimer treatment to improve several biomarkers.
August 10, 2020
Video
A team of researchers have added 3 new modifiable risk factors to a list of 9 known factors that increase the risk of developing dementia.
An expert in Alzheimer disease describes some of the struggles dementia patients might be going through during the COVID-19 pandemic.
August 07, 2020
Investigators found a 22% reduction in clinical decline at the 78-week cutoff in the intent to treat population in EMERGE who received high-dose aducanumab, with a similar reduction seen in the opportunity to complete population.
July 31, 2020
Three studies presented during the AAIC 2020 annual meeting show how frequent influenza vaccination help promote a gene-dependent reduction of Alzheimer disease by up to 40%.
July 24, 2020
As of February, 121 unique therapies are involved in clinical trials for Alzheimer disease, with putative disease-modifying agents targeting disease onset or progression accounting for the largest number.
July 08, 2020
Those who received the agent in EMERGE reported a significant slowing of decline on measures of cognition and function such as memory, orientation, and language, as well as for activities of daily living.
June 27, 2020
Those with ≥150 min per week in moderated or vigorous activities were low risk while those with less than 150 or sedentary activity were higher risk.
